Production of Human Pluripotent Stem Cell-Derived Hepatic Cell Lineages and Liver Organoids: Current Status and Potential Applications

Liver disease is one of the leading causes of death worldwide, leading to the death of approximately 2 million people per year. Current therapies include orthotopic liver transplantation, however, donor organ shortage remains a great challenge. In addition, the development of novel therapeutics has been limited due to the lack of in vitro models that mimic in vivo liver physiology. Accordingly, hepatic cell lineages derived from human pluripotent stem cells (hPSCs) represent a promising cell source for liver cell therapy, disease modelling, and drug discovery. Moreover, the development of new culture systems bringing together the multiple liver-specific hepatic cell types triggered the development of hPSC-derived liver organoids. Therefore, these human liver-based platforms hold great potential for clinical applications. In this review, the production of the different hepatic cell lineages from hPSCs, including hepatocytes, as well as the emerging strategies to generate hPSC-derived liver organoids will be assessed, while current biomedical applications will be highlighted.

[1]  S. Duncan,et al.  iPSC-Derived Hepatocytes as a Platform for Disease Modeling and Drug Discovery , 2019, Front. Med..

[2]  W. Jeong,et al.  Glutamate Signaling in Hepatic Stellate Cells Drives Alcoholic Steatosis. , 2019, Cell metabolism.

[3]  D. Brenner,et al.  The Crosstalk between Hepatocytes, Hepatic Macrophages, and Hepatic Stellate Cells Facilitates Alcoholic Liver Disease. , 2019, Cell metabolism.

[4]  Yuxin Su,et al.  Human ESC-derived expandable hepatic organoids enable therapeutic liver repopulation and pathophysiological modeling of alcoholic liver injury , 2019, Cell Research.

[5]  M. Kimura,et al.  Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids. , 2019, Cell metabolism.

[6]  Yuanyin Wang,et al.  Strategies for derivation of endothelial lineages from human stem cells , 2019, Stem Cell Research & Therapy.

[7]  Tiago G Fernandes,et al.  Transcriptomic analysis of 3D Cardiac Differentiation of Human Induced Pluripotent Stem Cells Reveals Faster Cardiomyocyte Maturation Compared to 2D Culture , 2019, Scientific Reports.

[8]  R. Cummings,et al.  Generation of fully functional hepatocyte-like organoids from human induced pluripotent stem cells mixed with Endothelial Cells , 2019, Scientific Reports.

[9]  Dominic Grün,et al.  A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.

[10]  A. Xu,et al.  Generation of hepatobiliary organoids from human induced pluripotent stem cells. , 2019, Journal of hepatology.

[11]  Joseph C. Wu,et al.  Generation of Endothelial Cells From Human Pluripotent Stem Cells. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Tiago G Fernandes,et al.  Design Principles for Pluripotent Stem Cell-Derived Organoid Engineering , 2019, Stem cells international.

[13]  S. Uemoto,et al.  Novel hybrid three-dimensional artificial liver using human induced pluripotent stem cells and a rat decellularized liver scaffold , 2019, Regenerative therapy.

[14]  George Q. Daley,et al.  Induced pluripotent stem cells in disease modelling and drug discovery , 2019, Nature Reviews Genetics.

[15]  Hanry Yu,et al.  Generation of mature kupffer cells from human induced pluripotent stem cells. , 2019, Biomaterials.

[16]  P. Kamath,et al.  Burden of liver diseases in the world. , 2019, Journal of hepatology.

[17]  J. Qin,et al.  In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. , 2018, Lab on a chip.

[18]  D. Ilic,et al.  Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy , 2018, Stem cells translational medicine.

[19]  D. Dimmock,et al.  A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome , 2018, Cell reports.

[20]  C. Rice,et al.  Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids , 2018, Cell.

[21]  A. Manfrin,et al.  Progress and potential in organoid research , 2018, Nature Reviews Genetics.

[22]  Tiago G Fernandes,et al.  A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies. , 2018, Toxicology letters.

[23]  D. Hay,et al.  3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo , 2018, Archives of Toxicology.

[24]  A. Ryo,et al.  Recapitulation of hepatitis B virus–host interactions in liver organoids from human induced pluripotent stem cells , 2018, EBioMedicine.

[25]  Milica Radisic,et al.  Advances in organ-on-a-chip engineering , 2018, Nature Reviews Materials.

[26]  Juan José Lozano,et al.  Generation of Hepatic Stellate Cells from Human Pluripotent Stem Cells Enables In Vitro Modeling of Liver Fibrosis. , 2018, Cell stem cell.

[27]  Tiago G Fernandes,et al.  Towards Multi-Organoid Systems for Drug Screening Applications , 2018, Bioengineering.

[28]  F. Lemaigre,et al.  Development of the liver: Insights into organ and tissue morphogenesis. , 2018, Journal of hepatology.

[29]  Pedro M. Baptista,et al.  Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells. , 2018, Gastroenterology.

[30]  Murat Cirit,et al.  Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies , 2018, Scientific Reports.

[31]  Gordana Vunjak-Novakovic,et al.  Organs-on-a-Chip: A Fast Track for Engineered Human Tissues in Drug Development. , 2018, Cell stem cell.

[32]  I. Weissman,et al.  A Roadmap for Human Liver Differentiation from Pluripotent Stem Cells , 2018, Cell reports.

[33]  H. Mizuguchi,et al.  Billion-scale production of hepatocyte-like cells from human induced pluripotent stem cells. , 2018, Biochemical and biophysical research communications.

[34]  H. Baharvand,et al.  Developing a Cost-Effective and Scalable Production of Human Hepatic Competent Endoderm from Size-Controlled Pluripotent Stem Cell Aggregates. , 2018, Stem Cells and Development.

[35]  H. Taniguchi,et al.  Human liver organoids generated with single donor-derived multiple cells rescue mice from acute liver failure , 2018, Stem Cell Research & Therapy.

[36]  A. Lyne,et al.  Mouse decellularised liver scaffold improves human embryonic and induced pluripotent stem cells differentiation into hepatocyte-like cells , 2017, PloS one.

[37]  K. Sekine,et al.  Massive and Reproducible Production of Liver Buds Entirely from Human Pluripotent Stem Cells. , 2017, Cell reports.

[38]  S. Friedman,et al.  Hepatic stellate cells as key target in liver fibrosis. , 2017, Advanced drug delivery reviews.

[39]  O. Ohara,et al.  Generation of safe and therapeutically effective human induced pluripotent stem cell‐derived hepatocyte‐like cells for regenerative medicine , 2017, Hepatology communications.

[40]  J. Sage,et al.  Human hepatic organoids for the analysis of human genetic diseases. , 2017, JCI Insight.

[41]  Katsuhiko Shirahige,et al.  An In Vitro Human Liver Model by iPSC-Derived Parenchymal and Non-parenchymal Cells , 2017, Stem cell reports.

[42]  Murat Cirit,et al.  Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk , 2017, Biotechnology and bioengineering.

[43]  H. Binder,et al.  Multilineage communication regulates human liver bud development from pluripotency , 2017, Nature.

[44]  S. Friedman,et al.  Mechanisms of hepatic stellate cell activation , 2017, Nature Reviews Gastroenterology &Hepatology.

[45]  Zuojin Liu,et al.  The role of Kupffer cells in hepatic diseases , 2017, Molecular immunology.

[46]  D. Rader,et al.  A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia. , 2017, Cell stem cell.

[47]  H. Clevers,et al.  Long-Term Adult Feline Liver Organoid Cultures for Disease Modeling of Hepatic Steatosis , 2017, Stem cell reports.

[48]  T. Takebe,et al.  Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells , 2017, Development.

[49]  Takashi Daimon,et al.  Autologous Induced Stem‐Cell–Derived Retinal Cells for Macular Degeneration: Brief Report , 2017, The New England journal of medicine.

[50]  Shinya Yamanaka,et al.  Induced pluripotent stem cell technology: a decade of progress , 2016, Nature Reviews Drug Discovery.

[51]  Oksana Sirenko,et al.  Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis , 2016, Assay and drug development technologies.

[52]  S. Tasoglu,et al.  A Bioprinted Liver-on-a-Chip for Drug Screening Applications. , 2016, Trends in biotechnology.

[53]  A. Weber,et al.  The potential of induced pluripotent stem cell derived hepatocytes. , 2016, Journal of hepatology.

[54]  H. Mizuguchi,et al.  Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure. , 2016, Journal of hepatology.

[55]  Zongyi Hu,et al.  Hepatic differentiation of human pluripotent stem cells in miniaturized format suitable for high-throughput screen. , 2016, Stem cell research.

[56]  Nazish Sayed,et al.  Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. , 2016, Journal of the American College of Cardiology.

[57]  E. Cuppen,et al.  Generation and characterization of rat liver stem cell lines and their engraftment in a rat model of liver failure , 2016, Scientific Reports.

[58]  Nick Barker,et al.  Organoids as an in vitro model of human development and disease , 2016, Nature Cell Biology.

[59]  B. Kerem,et al.  Genomic Instability in Human Pluripotent Stem Cells Arises from Replicative Stress and Chromosome Condensation Defects. , 2016, Cell stem cell.

[60]  N. Benvenisty,et al.  Pluripotent stem cells in disease modelling and drug discovery , 2016, Nature Reviews Molecular Cell Biology.

[61]  Jeffrey M Karp,et al.  Engineering Stem Cell Organoids. , 2016, Cell stem cell.

[62]  Zara Hannoun,et al.  Transplantation of hESC-derived hepatocytes protects mice from liver injury , 2015, Stem Cell Research & Therapy.

[63]  Robert Preissner,et al.  WITHDRAWN—a resource for withdrawn and discontinued drugs , 2015, Nucleic Acids Res..

[64]  C. Chen,et al.  Disease Modeling and Gene Therapy of Copper Storage Disease in Canine Hepatic Organoids , 2015, Stem cell reports.

[65]  Robert Lanza,et al.  Current status of pluripotent stem cells: moving the first therapies to the clinic , 2015, Nature Reviews Drug Discovery.

[66]  B. Smedsrød,et al.  Liver Sinusoidal Endothelial Cells. , 2015, Comprehensive Physiology.

[67]  G. Keller,et al.  Directed differentiation of cholangiocytes from human pluripotent stem cells , 2015, Nature Biotechnology.

[68]  T. Karlsen,et al.  Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation , 2015, Nature Biotechnology.

[69]  T. Evans,et al.  Orchestrating liver development , 2015, Development.

[70]  Roger A. Pedersen,et al.  Brachyury and SMAD signalling collaboratively orchestrate distinct mesoderm and endoderm gene regulatory networks in differentiating human embryonic stem cells , 2015, Development.

[71]  S. Strom,et al.  Amelioration of Hyperbilirubinemia in Gunn Rats after Transplantation of Human Induced Pluripotent Stem Cell-Derived Hepatocytes , 2015, Stem cell reports.

[72]  Salman R Khetani,et al.  Prediction of Drug-Induced Liver Injury in Micropatterned Co-cultures Containing iPSC-Derived Human Hepatocytes. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[73]  Elena Naumovska,et al.  Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells , 2015, Stem cell reports.

[74]  Y. Li,et al.  Development and Characterization of Human Induced Pluripotent Stem Cell-Derived Cholangiocytes , 2015, Laboratory Investigation.

[75]  Hans Clevers,et al.  Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver , 2015, Cell.

[76]  S. Thorgeirsson,et al.  Engrafted human stem cell-derived hepatocytes establish an infectious HCV murine model. , 2014, The Journal of clinical investigation.

[77]  Sonja Nowotschin,et al.  SOX17 links gut endoderm morphogenesis with germ layer segregation , 2014, Nature Cell Biology.

[78]  D. Ingber,et al.  Microfluidic organs-on-chips , 2014, Nature Biotechnology.

[79]  Peter Reinhardt,et al.  Investigating human disease using stem cell models , 2014, Nature Reviews Genetics.

[80]  Juergen A. Knoblich,et al.  Organogenesis in a dish: Modeling development and disease using organoid technologies , 2014, Science.

[81]  Sangeeta N. Bhatia,et al.  Cell and tissue engineering for liver disease , 2014, Science Translational Medicine.

[82]  L. Combettes,et al.  Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells , 2014, Hepatology.

[83]  A. Miyajima,et al.  Stem/progenitor cells in liver development, homeostasis, regeneration, and reprogramming. , 2014, Cell stem cell.

[84]  S. Bhatia,et al.  Pluripotent stem cell-derived hepatocyte-like cells. , 2014, Biotechnology advances.

[85]  K. Sekine,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[86]  D. Hay,et al.  Developing High‐Fidelity Hepatotoxicity Models From Pluripotent Stem Cells , 2013, Stem cells translational medicine.

[87]  Hossein Baharvand,et al.  Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. , 2013, Stem cells and development.

[88]  Yoon-Young Jang,et al.  Efficient drug screening and gene correction for treating liver disease using patient‐specific stem cells , 2013, Hepatology.

[89]  H. Clevers,et al.  In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration , 2013, Nature.

[90]  Fred H. Gage,et al.  Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.

[91]  Takashi Aoi,et al.  Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells , 2012, Proceedings of the National Academy of Sciences.

[92]  T. Koyama,et al.  Induction of LYVE-1/stabilin-2-positive liver sinusoidal endothelial-like cells from embryoid bodies by modulation of adrenomedullin-RAMP2 signaling , 2011, Peptides.

[93]  T. Adachi,et al.  Self-organizing optic-cup morphogenesis in three-dimensional culture , 2011, Nature.

[94]  W. Pu,et al.  Septum transversum‐derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver , 2011, Hepatology.

[95]  R. Pedersen,et al.  Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development , 2010, Hepatology.

[96]  F. Lemaigre,et al.  Organogenesis and development of the liver. , 2010, Developmental cell.

[97]  Stephen Dalton,et al.  Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.

[98]  Jehyuk Lee,et al.  Generation of functional human hepatic endoderm from human induced pluripotent stem cells , 2009, Hepatology.

[99]  Xiaolei Yin,et al.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells , 2009, Cell Research.

[100]  H. Deng,et al.  Derivation and Characterization of Hepatic Progenitor Cells from Human Embryonic Stem Cells , 2009, PloS one.

[101]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[102]  A. Kispert,et al.  09-P045 C/EBP alpha initiates primitive myelopoiesis in pluripotent embryonic cells , 2009, Mechanisms of Development.

[103]  M. Tomishima,et al.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling , 2009, Nature Biotechnology.

[104]  A. Hadjantonakis,et al.  The endoderm of the mouse embryo arises by dynamic widespread intercalation of embryonic and extraembryonic lineages. , 2008, Developmental cell.

[105]  Catherine Payne,et al.  Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling , 2008, Proceedings of the National Academy of Sciences.

[106]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[107]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[108]  J. Itskovitz‐Eldor,et al.  Directed differentiation of human embryonic stem cells into functional hepatic cells , 2007, Hepatology.

[109]  K. Kaestner,et al.  An FGF response pathway that mediates hepatic gene induction in embryonic endoderm cells. , 2006, Developmental cell.

[110]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[111]  K. Zaret,et al.  Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. , 2006, Developmental biology.

[112]  P. Courtoy,et al.  Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. , 2005, Genes & development.

[113]  K. Zaret,et al.  Distinct populations of endoderm cells converge to generate the embryonic liver bud and ventral foregut tissues. , 2005, Developmental biology.

[114]  J. Wells,et al.  Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung , 2004, Development.

[115]  Gordon Keller,et al.  Development of definitive endoderm from embryonic stem cells in culture , 2004, Development.

[116]  D. Norris,et al.  Cell fate decisions within the mouse organizer are governed by graded Nodal signals. , 2003, Genes & development.

[117]  J. Adamson,et al.  Hepatocyte nuclear factor 4α controls the development of a hepatic epithelium and liver morphogenesis , 2003, Nature Genetics.

[118]  Pratima Kundu,et al.  Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells , 2003, Cell transplantation.

[119]  D. Stolz,et al.  Histological organization in hepatocyte organoid cultures. , 2001, The American journal of pathology.

[120]  J. Rossant,et al.  Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function , 2001, Science.

[121]  B. Hogan,et al.  Distinct mesodermal signals, including BMPs from the septum transversum mesenchyme, are required in combination for hepatogenesis from the endoderm. , 2001, Genes & development.

[122]  M. Kuehn,et al.  Genetic dissection of nodal function in patterning the mouse embryo. , 2001, Development.

[123]  A. Miyajima,et al.  Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways , 2001, FEBS letters.

[124]  Guillermo Oliver,et al.  Hepatocyte migration during liver development requires Prox1 , 2000, Nature Genetics.

[125]  Yoshiaki Ito,et al.  Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer , 1999, The EMBO journal.

[126]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[127]  H. Niwa,et al.  Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. , 1996, Experimental cell research.

[128]  J. R. Coleman,et al.  Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. , 1996, Genes & development.

[129]  R. Pedersen,et al.  The role of E-cadherin and integrins in mesoderm differentiation and migration at the mammalian primitive streak. , 1993, Development.

[130]  M. Kusano,et al.  Hepatocyte Transplantation in Man , 1992, Transplantation proceedings.

[131]  R. Pedersen,et al.  Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. , 1991, Development.

[132]  G. Martin,et al.  Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[133]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[134]  A. Matas,et al.  Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. , 1976, Science.

[135]  Tiago G Fernandes,et al.  Pluripotent stem cell biology and engineering , 2020 .

[136]  A. Dhawan,et al.  Human hepatocyte transplantation for liver disease: current status and future perspectives , 2018, Pediatric Research.

[137]  Richard Moreau,et al.  Liver sinusoidal endothelial cells: Physiology and role in liver diseases. , 2017, Journal of hepatology.

[138]  S. Friedman Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.